Skip to main content
. 2014 Sep 2;74(14):1587–1603. doi: 10.1007/s40265-014-0278-5

Fig. 7.

Fig. 7

Simulated rivaroxaban plasma concentration–time profiles for a virtual population of patients with atrial fibrillation (with permission [56]). For patients with mildly impaired or normal CrCl (>50 mL/min), exposure is the same with a 20 mg od dose as for patients with moderate renal impairment (≤50 mL/min) with a 15 mg od dose. CrCl creatinine clearance, od once daily